Form 8-K Coherus BioSciences, For: Sep 08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Coherus BioSciences (CHRS) Increases ATM Offering Program by $28.75M
September 12, 2023 6:14 AM EDTOn May 15, 2023, Coherus BioSciences (NASDAQ: CHRS) previously announced that it reduced the amount of shares that could be issued and sold pursuant to its at-the-market program (ATM) with Cowen and Company, LLC (TD Cowen) in an amount equal to $86.25 million. The reduction in the amount... More



